Newswires
Submission of Matters to a Vote of Security Holders – Form 8-K
tndm-20230524
UNITED STATES
Washington, D.C. 20549
Tandem Diabetes Care, Inc.
SECURITIES AND EXCHANGE COMMISSION
____________________________
FORM 8-K
____________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 24, 2023
____________________________
(Exact name of registrant as specified in its charter)
_________
| 001-36189 | 20-4327508 | |
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
| 92130 | ||
| ( |
||
| (Address of principal executive offices) |
Registrant's telephone number, including area code: (858) 366-6900
N/A
(Former name or former address, if changed since last report)
____________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
| Title of Each Class | Symbol | |
| Common Stock, par value |
TNDM | Nasdaq Global Market |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐
___________________________
Item 5.07 Submission of Matters to a Vote of Security Holders.
On May 24, 2023 , Tandem Diabetes Care, Inc. (the "Company") held a virtual Annual Meeting of Stockholders (the "Annual Meeting"). There were 64,606,732 shares of the Company's common stock ("Common Stock") outstanding on March 28, 2023 , the record date for the Annual Meeting. At the Annual Meeting, 58,914,493 shares of Common Stock were present virtually or represented by proxy.
The following tables set forth the final results of the voting for the matters voted upon at the Annual Meeting. These matters are described in more detail in the Company's definitive proxy statement, filed with the Securities and Exchange Commission (the "SEC") on April 12, 2023 (the "Proxy Statement").
Proposal 1: To elect four Class I and three Class III directors for a one-year term expiring at the 2024 annual meeting of stockholders. The stockholders elected four Class I and three Class III directors by the following votes:
| For | Against | Abstain | Broker Non-Votes | |
| 47,663,540 | 8,307,290 | 23,189 | 2,920,474 | |
| Myoungil Cha | 46,739,317 | 9,178,406 | 76,296 | 2,920,474 |
| 46,122,306 | 9,788,662 | 83,051 | 2,920,474 | |
| Joao Paulo Falcao Malagueira | 54,961,819 | 955,155 | 77,045 | 2,920,474 |
| 46,417,748 | 9,501,237 | 75,034 | 2,920,474 | |
| 47,034,251 | 8,936,456 | 23,312 | 2,920,474 | |
| 46,184,111 | 9,732,168 | 77,740 | 2,920,474 |
Proposal 2: To approve the Company's 2023 Long-Term Incentive Plan, which will replace the 2013 Stock Incentive Plan expiring on November 15, 2023 . The proposal received the following votes:
| For | Against | Abstain | Broker Non-Votes |
| 51,791,463 | 4,104,680 | 97,876 | 2,920,474 |
Proposal 3: To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers. The proposal received the following votes:
| For | Against | Abstain | Broker Non-Votes |
| 45,684,932 | 10,258,454 | 50,633 | 2,920,474 |
Proposal 4: To ratify of the appointment of Ernst & Young LLP to serve as the Company's independent registered public accountant for the year ending December 31, 2023 . The proposal received the following votes:
| For | Against | Abstain | Broker Non-Votes |
| 58,058,014 | 790,996 | 65,483 |
Item 5.08Shareholder Director Nominations.
A proposal submitted by a stockholder for inclusion in the proxy materials for the Company's 2024 annual meeting of stockholders (the "2024 Annual Meeting"), must be received by the Company's Corporate Secretary at 12400 High Bluff Drive , San Diego, CA 92130 on or before December 14, 2023 and comply with the requirements of Rule 14a-8 of the Exchange Act of 1934, as amended.
In addition, a stockholder who wishes to submit a proposal for consideration at the 2024 Annual Meeting without including that proposal in the proxy materials for that meeting must notify the Company of that proposal no earlier than the close of business on January 25, 2024 , and no later than the close of business on February 24, 2024 . The Company's Amended and Restated Bylaws specify requirements regarding the delivery of any such notice and the inclusion of any such proposal to be considered at the 2024 Annual Meeting.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
By:
|
/s/ |
| Senior Vice President, General Counsel, Corporate Secretary & Chief Compliance Officer |
Date: May 25, 2023
Attachments
Disclaimer
Security Council Urged to Step up On Financing for AU Peace Operations
Merger Agreement – Form 8-K
Advisor News
- Millennials are ready to bring their advisor to the family table
- How healthcare inflation can eat up a client’s retirement income
- Global economy ‘resilient’ in the wake of massive disruption
- Cryptocurrency legislation takes one step forward with bipartisan support
- IRS CEO FRANK J. BISIGNANO VISITS OHIO TO TOUT WORKING FAMILIES TAX CUTS PROVISIONS ON NO TAX ON CAR LOAN INTEREST, NO TAX ON OVERTIME, ENHANCED DEDUCTION FOR SENIOR CITIZENS
More Advisor NewsAnnuity News
- Wink: Flat first-quarter annuity sales fall just short of $100B
- 26North Re Agrees to Acquire 100% of Independent Insurance Group
- Matthew Michelini named Athene president, with an eye on annuity growth
- Lincoln Financial Announces Executive Leadership Transitions
- MetLife Expands Guaranteed Retirement Income Offering with Innovative Flexible Annuity Option
More Annuity NewsHealth/Employee Benefits News
- New Managed Care Findings Has Been Reported by Researchers at Duke University Medical Center (Access to pediatric eye care among Medicaid-insured children in North Carolina): Managed Care
- Researchers from West Virginia University Detail Findings in Managed Care (Under the Same Umbrella: Public Health Insurance Expansions and the Uniformity of Insurance for Families): Managed Care
- Findings on Managed Care Reported by Investigators at School of Medicine (American Medical Women’s Association Position Statement On Period Poverty: Advancing Menstrual Equity Through Health Coverage Reform): Managed Care
- New Mental Health Diseases and Conditions Data Have Been Reported by Investigators at Stanford University (Self-funded Group Health Plans: a Public Mental Health Threat To Employees?): Mental Health Diseases and Conditions
- Research Conducted at National Center for Chronic Diseases Prevention and Health Promotion Has Updated Our Knowledge about Managed Care (Knowledge, Perceptions, and Barriers To Collection of Family Health History Data): Managed Care
More Health/Employee Benefits NewsLife Insurance News
- Study Data from National Institutes of Health Provide New Insights into Law and the Biosciences (Taking actuarial fairness seriously: what is required for the ethical use of genetics in insurance?): Legal Issues – Law and the Biosciences
- 26North Re Agrees to Acquire 100% of Independent Insurance Group
- Lincoln Financial Announces Executive Leadership Transitions
- Setting the record straight on premium-financed IUL
- AM Best Affirms Credit Ratings of Halyk-Life, JSC
More Life Insurance News